BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19595600)

  • 1. NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs.
    Calderone V; Rapposelli S; Martelli A; Digiacomo M; Testai L; Torri S; Marchetti P; Breschi MC; Balsamo A
    Bioorg Med Chem; 2009 Aug; 17(15):5426-32. PubMed ID: 19595600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents.
    Xie Y; Shao L; Wang Q; Bai Y; Chen Z; Li N; Xu Y; Li Y; Yang G; Bian X
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3731-3735. PubMed ID: 30343953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
    Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
    Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid.
    Lazzarato L; Donnola M; Rolando B; Marini E; Cena C; Coruzzi G; Guaita E; Morini G; Fruttero R; Gasco A; Biondi S; Ongini E
    J Med Chem; 2008 Mar; 51(6):1894-903. PubMed ID: 18293898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
    Gresele P; Momi S
    Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins.
    Lazzarato L; Donnola M; Rolando B; Chegaev K; Marini E; Cena C; Di Stilo A; Fruttero R; Biondi S; Ongini E; Gasco A
    J Med Chem; 2009 Aug; 52(16):5058-68. PubMed ID: 20560642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrosyl-cobinamide, a new and direct nitric oxide releasing drug effective in vivo.
    Broderick KE; Alvarez L; Balasubramanian M; Belke DD; Makino A; Chan A; Woods VL; Dillmann WH; Sharma VS; Pilz RB; Bigby TD; Boss GR
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1432-40. PubMed ID: 18040067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties.
    Boschi D; Tron GC; Lazzarato L; Chegaev K; Cena C; Di Stilo A; Giorgis M; Bertinaria M; Fruttero R; Gasco A
    J Med Chem; 2006 May; 49(10):2886-97. PubMed ID: 16686532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs.
    López GV; Batthyány C; Blanco F; Botti H; Trostchansky A; Migliaro E; Radi R; González M; Cerecetto H; Rubbo H
    Bioorg Med Chem; 2005 Oct; 13(20):5787-96. PubMed ID: 15993614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
    López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
    Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New nitric oxide or hydrogen sulfide releasing aspirins.
    Lazzarato L; Chegaev K; Marini E; Rolando B; Borretto E; Guglielmo S; Joseph S; Di Stilo A; Fruttero R; Gasco A
    J Med Chem; 2011 Aug; 54(15):5478-84. PubMed ID: 21688846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
    Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
    J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.
    Lazzarato L; Cena C; Rolando B; Marini E; Lolli ML; Guglielmo S; Guaita E; Morini G; Coruzzi G; Fruttero R; Gasco A
    Bioorg Med Chem; 2011 Oct; 19(19):5852-60. PubMed ID: 21906954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.
    Chegaev K; Lazzarato L; Tosco P; Cena C; Marini E; Rolando B; Carrupt PA; Fruttero R; Gasco A
    J Med Chem; 2007 Apr; 50(7):1449-57. PubMed ID: 17335184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
    Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the NO-releasing properties of NO-donor linkers.
    Calderone V; Digiacomo M; Martelli A; Minutolo F; Rapposelli S; Testai L; Balsamo A
    J Pharm Pharmacol; 2008 Feb; 60(2):189-95. PubMed ID: 18237466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Defective nitric oxide homeostasis. Common underlying mechanism between insulin resistance, sympathetic overactivity and cardiovascular morbidity and mortality].
    Schwab M; Bloch J; Duplain H; Sartori C; Scherrer U
    Medicina (B Aires); 2008; 68(3):243-50. PubMed ID: 18689158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications.
    Digiacomo M; Martelli A; Testai L; Lapucci A; Breschi MC; Calderone V; Rapposelli S
    Bioorg Med Chem; 2015 Feb; 23(3):422-8. PubMed ID: 25577707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
    Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
    J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel analgesic/anti-inflammatory agents: diarylpyrrole acetic esters endowed with nitric oxide releasing properties.
    Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; Rovini M; Valenti S; Giorgi G; Calderone V; Martelli A; Testai L; Sautebin L; Rossi A; Papa G; Ghelardini C; Di Cesare Mannelli L; Giordani A; Anzellotti P; Bruno A; Patrignani P; Anzini M
    J Med Chem; 2011 Nov; 54(22):7759-71. PubMed ID: 21992176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.